NSE · ARTEMISMED
Artemis Medicare Services Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹282 Cr with net profit ₹31 Cr — a 11.01% net margin, versus 9.33% the period before.
Shareholding
As of 2026-06-30
- Promoter58.39%
- Public26.92%
- FII12.29%
- DII2.4%
36,335 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.78× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Healthcare · ranked #23 of 85 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,25,042 Cr | 59.43 | 13.21 | 20.48% | 7.91% |
| Max Healthcare Institute Ltd. | ₹99,764 Cr | 66.64 | 9.35 | 13.42% | 16.73% |
| Manipal Health Enterpri Limited | ₹93,997 Cr | 100.22 | 5.72 | 10.59% | 7.81% |
| Fortis Healthcare Ltd. | ₹65,704 Cr | 61.59 | 6.63 | 10.53% | 11.02% |
| Aster DM Quality Care Ltd. | ₹64,504 Cr | 166.29 | 15.35 | 8.48% | 6.54% |
| Narayana Hrudayalaya Ltd. | ₹37,839 Cr | 43.9 | 8.34 | 17.76% | 9% |
| Global Health Limited | ₹37,766 Cr | 65.97 | 9.54 | 14.05% | 11.88% |
| Krishna Institute of Medical Sciences Ltd. | ₹32,200 Cr | 154.26 | 8.6 | 10.74% | 4.85% |
| Dr. Lal Path Labs Ltd. | ₹31,819 Cr | 56.57 | 12.67 | 20.13% | 18.75% |
| Poly Medicure Ltd. | ₹17,239 Cr | 53.87 | 5.57 | 10.37% | 15.77% |
| Artemis Medicare Services Ltd.(this company) | ₹5,149 Cr | 44.43 | 5.96 | 11.09% | 10.21% |
AI analysis
AI-generated · google/gemini-2.5-flashArtemis Medicare Services Ltd. (ARTEMISMED) has a market capitalization of Rs 4264 Cr. The company reported revenue of Rs 969.9 Cr and an EPS of 6.07. Its book value is Rs 56.2 and it has a debt-to-equity ratio of 0.51. The 52-week high for the share price was Rs 297.5 and the 52-week low was Rs 203.35.
Positives
- +The Return on Equity (ROE) of 14.4% indicates efficient use of shareholder funds.
- +The Return on Capital Employed (ROCE) of 13.9487% suggests good capital deployment efficiency.
- +The percentage of DII holding increased from 0.9082% in Sep 2021 to 2.3974% in Jun 2026.
- +The number of shareholders increased significantly from 10765 in Sep 2021 to 36335 in Jun 2026.
Negatives
- −A high percentage of promoter shares, 44.53%, is pledged as of June 30, 2026.
- −The debt-to-equity ratio of 0.51 indicates a moderate level of debt.
- −Promoter holding decreased from 69.8239% in Sep 2021 to 58.3929% in Jun 2026.
Financial Performance
For the period ending Mar 2026, the company reported an annual revenue of Rs 1111.0716 Cr and a net profit of Rs 103.6192 Cr, with an EPS of 6.56. Quarterly results show revenue of Rs 279.23 Cr and net profit of Rs 30.03 Cr for Mar 2026. The EBITDA for the annual period ending Mar 2026 was Rs 169.9394 Cr.
Profitability & Returns
The company's Return on Equity (ROE) stands at 14.4%, while the Return on Capital Employed (ROCE) is 13.9487%. The EPS is 6.07. The company's PE ratio is 45.26.
Balance Sheet
Artemis Medicare Services Ltd. has a debt-to-equity ratio of 0.51, indicating its leverage. The book value per share is Rs 56.2. No further details regarding assets or liabilities are provided in the available data.
Ownership & Pledges
The public shareholding stands at 26.9233%. A significant portion of promoter shares, 44.53%, is pledged as of June 30, 2026.
Data as of — price: 2026-09-17 · financials: Jun 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Artemis Medicare Services Ltd.share price & fundamentals